PVI
TXG icon

Pura Vida Investments’s 10x Genomics TXG Stock Holding History

Pura Vida Investments’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100,000
Closed -$2.85M – 248
2022
Q3 		$2.85M Sell
100,000
-150,000
-60% -$5.71M 0.16% 115
2022
Q2 		$11.3M Sell
250,000
-34,400
-12% -$1.78M 0.66% 42
2022
Q1 		$21.6M Buy
284,400
+107,000
+60% +$9.36M 0.7% 33
2021
Q4 		$26.4M Buy
177,400
+17,400
+11% +$2.67M 0.96% 25
2021
Q3 		$23.3M Buy
160,000
+95,000
+146% +$16.3M 0.71% 33
2021
Q2 		$12.7M Buy
+65,000
New +$11.8M 0.4% 58

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Pura Vida Investments's TXG Position: Q2 2024 in Review

Pura Vida Investments sold out of 10x Genomics (TXG) in Q2 2024, closing a stake of 38,005 shares — an estimated $1.43M sold.

Pura Vida Investments first reported a position in TXG in Q3 2019 and held it in 12 quarters. The position peaked at $12.8M in Q1 2021. 261 funds tracked by Wall St. Rank hold TXG as of Q2 2024.

  • Pura Vida Investments reported no remaining 10x Genomics position as of Q2 2024 after selling out during the quarter.
  • Pura Vida Investments sold 38,005 10x Genomics shares in Q2 2024, an estimated $1.43M.
  • Pura Vida Investments first reported a position in 10x Genomics in Q3 2019 and held it in 12 quarters.
  • Pura Vida Investments's 10x Genomics position peaked at $12.8M in Q1 2021.
  • 261 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2024.

Based on Pura Vida Investments's 13F filing for Q2 2024, filed 14 Aug 2024.